CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer-Reference-Cited by-同舟云学术

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer

Published:2019-11 Issue:8 Volume:29 Page:2355-2370.e6
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Hwang Justin H.,Seo Ji-Heui,Beshiri Michael L.,Wankowicz Stephanie,Liu David,Cheung Alexander,Li Ji,Qiu Xintao,Hong Andrew L.,Botta Ginevra,Golumb Lior,Richter Camden,So Jonathan,Sandoval Gabriel J.,Giacomelli Andrew O.,Ly Seav Huong,Han Celine,Dai Chao,Pakula Hubert,Sheahan Anjali,Piccioni Federica,Gjoerup Ole,Loda Massimo,Sowalsky Adam G.,Ellis Leigh,Long Henry,Root David E.,Kelly Kathleen,Van Allen Eliezer M.,Freedman Matthew L.,Choudhury Atish D.,Hahn William C.

Funder

American Cancer Society

National Cancer Institute

U.S. Department of Defense

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference59 articles.

1. Current understanding of resistance to abiraterone and enzalutamide in advanced prostate cancer;Antonarakis;Clin. Adv. Hematol. Oncol.,2016

2. The long tail of oncogenic drivers in prostate cancer;Armenia;Nat. Genet.,2018

3. Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade;Arora;Cell,2013